Kiniksa Pharmaceuticals International, plc Stock Analysis & AI Score
Kiniksa Pharmaceuticals International, plc (KNSA) has an ST Score of 63.3 (B), driven by its Profitability (A) and held back by its Valuation (F). Analysts rate it Buy with a $86.40 price target (+14.7% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Kiniksa Pharmaceuticals International, plc (KNSA) has an ST Score of 63.3 (B), driven by its Profitability (A) and held back by its Valuation (F). Analysts rate it Buy with a $86.40 price target (+14.7% upside).
- Strongest
- ProfitabilityA
- Weakest
- ValuationF
All factor grades
- ProfitabilityA
- Financial StrengthA
- MomentumA
- GrowthB
- ForecastB-
- ValuationF
- Piotroski6/9
Contact
KNSA stock: frequently asked questions
What is KNSA's ST Score?
Kiniksa Pharmaceuticals International, plc (KNSA) has an ST Score of 63.3 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is KNSA a buy, hold, or sell?
Analysts rate KNSA a Buy, with a price target of $86.40 (+14.7% vs the current price). Our ST Score grades it B (63.3/100). The ST Score is a data-driven signal, not a recommendation.
What are KNSA's factor grades?
Valuation F, Profitability A, Financial Strength A, Momentum A, Growth B, Forecast B-.
What is KNSA's valuation grade?
Kiniksa Pharmaceuticals International, plc (KNSA) earns a valuation grade of F, measured against Medical - Pharmaceuticals peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is KNSA's growth grade?
Kiniksa Pharmaceuticals International, plc (KNSA) earns a growth grade of B, measured against Medical - Pharmaceuticals peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is KNSA's profitability grade?
Kiniksa Pharmaceuticals International, plc (KNSA) earns a profitability grade of A, measured against Medical - Pharmaceuticals peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is KNSA's financial strength grade?
Kiniksa Pharmaceuticals International, plc (KNSA) earns a financial strength grade of A, measured against Medical - Pharmaceuticals peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for KNSA?
The average analyst price target for Kiniksa Pharmaceuticals International, plc (KNSA) is $86.40 from 11 analysts, which is +14.7% versus the recent price of $75.34.
What is KNSA's Piotroski score?
Kiniksa Pharmaceuticals International, plc (KNSA) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.